Ocular Therapeutix (OCUL) Interest Coverage Ratio Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 15.31%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -76.51%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -303.06%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - 18.06%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -26.72%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,150.63%
10 Ocular Therapeutix 1.99 Bn 1.99 Bn 9.46 Mn -56.92%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -56.92%
Dec 31, 2025 -51.28%
Sep 30, 2025 -60.39%
Jun 30, 2025 -64.44%
Mar 31, 2025 -174.45%
Dec 31, 2024 -237.12%
Sep 30, 2024 -154.40%
Jun 30, 2024 -32.01%
Mar 31, 2024 38.81%
Dec 31, 2023 53.92%
Sep 30, 2023 53.22%
Jun 30, 2023 12.02%
Mar 31, 2023 -20.37%
Dec 31, 2022 2.43%
Sep 30, 2022 -1.78%
Jun 30, 2022 3.94%
Mar 31, 2022 12.05%
Dec 31, 2021 -29.28%
Sep 30, 2021 -44.23%
Jun 30, 2021 -15.79%
Mar 31, 2021 -18.42%
Dec 31, 2020 29.91%
Sep 30, 2020 41.74%
Jun 30, 2020 20.47%
Mar 31, 2020 47.31%
Dec 31, 2019 74.34%
Sep 30, 2019 59.88%
Jun 30, 2019 55.47%
Mar 31, 2019 30.25%
Dec 31, 2018 -78.07%
Sep 30, 2018 -12.91%
Jun 30, 2018 23.92%
Mar 31, 2018 21.74%
Dec 31, 2017 13.02%
Sep 30, 2017 -42.72%
Jun 30, 2017 -47.47%
Mar 31, 2017 -40.71%
Dec 31, 2016 -18.48%
Sep 30, 2016 21.21%
Jun 30, 2016 -11.69%
Mar 31, 2016 -78.49%
Dec 31, 2015 -35.81%
Sep 30, 2015 -67.34%
Jun 30, 2015 -2.83%
Mar 31, 2015 91.13%
Dec 31, 2014 50.65%
Sep 30, 2014 54.99%
Jun 30, 2014 17.18%